After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

Published Date: 29 Dec 2023

According to a randomized study, prophylaxis can be safely and effectively extended from 100 to 200 days.

Read Full News

Latest News

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Todays Updates

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Latest News

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Not surprisingly, trust in government health agencies for cancer info has dipped

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

News, features, and commentary about cancer-related issues

Observational study shows greater microplastic burden in patients with lung malignancy

Health news and commentary gathered by MedPage Today staff

News All Time

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

If approved, immunotherapy gotistobart could offer a chemo-free option in second-line setting

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Early efficacy among the highest seen in lung cancer, expert says

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Case highlights need for quick diagnosis and management of rare disorder

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Ivonescimab topped pembrolizumab alone or paired with chemotherapy in separate trials

Patient's Colonoscopy Refusal Highlights Value of CRC Screening

Man with a first-degree relative with CRC initially only agreed to stool-based testing

RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

News, features, and commentary about cancer-related issues

FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test

— Comments were noncommittal in agency document released ahead of advisors' meeting

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder ⁠in a second successful late-stage study for the...
HTTP error: 503HTTP error: 503

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.
HTTP error: 503

Less Seniors Taking Inappropriate Cognitive Meds

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

US Health Department Seeks Public Feedback on Vaccine Guidelines After Trump Order

The U.S. health department said on Friday it was seeking public feedback on federal vaccine recommendations, including how they ⁠are categorized and communicated, after...

Alzheimer's Blood Test Gets FDA Clearance

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood ⁠test to help identify signs of Alzheimer's disease in people aged 55 and older with...

Recommended News For You

Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

Talc Powder Not Linked to Lung Cancer in Women

FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

The FDA Approves the New Frontline Aggressive ALL Regimen.

Recommended Articles For You

Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes 

Epigenetic Subtyping of Complex Hematologic Disorders 

Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management  

Understanding Mean Corpuscular Volume: A Comprehensive Guide  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

2.

Hematocrit Stabilized in Polycythemia Vera Under Novel Hepcidin Mimetic Treatment.

3.

Inside the Major Findings From the NHS-Galleri Trial

4.

Making informed decisions and managing regret after prostate cancer treatment

5.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

1.

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide

2.

Exploring the Latest Advances in PTLD Cancer Treatment

3.

Preventing Functional Iron Deficiency in High-Risk Populations

4.

AI Models for Multimodal Cancer Tissue Representation

5.

Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

2.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

3.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

4.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot